Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

The gel is safe and effective for treating oral mucositis from chemotherapy and radiation.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Abrocitinib may effectively treat stubborn alopecia universalis.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

Baricitinib is effective as a treatment for severe hair loss.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

Applying pseudoceramide improved skin and hair health.

Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Tridax procumbens may boost the immune system.

A 13-year-old girl with various symptoms was successfully treated for autoimmune disease using the antibiotic co-trimoxazole.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Belatacept may be a promising treatment for alopecia areata.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.